摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-甲氧基苯基)-2-甲基哌嗪 | 83949-40-0

中文名称
1-(3-甲氧基苯基)-2-甲基哌嗪
中文别名
——
英文名称
1-(3-methoxyphenyl)-2-methylpiperazine
英文别名
1-(3-methoxyphenyl)-4-(2-methyl)piperazine;N-(3-methoxyphenyl)-2-methylpiperazine
1-(3-甲氧基苯基)-2-甲基哌嗪化学式
CAS
83949-40-0
化学式
C12H18N2O
mdl
MFCD00044821
分子量
206.288
InChiKey
VIUHJEYRGSUXOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    348.3±27.0 °C(Predicted)
  • 密度:
    1.022±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    24.5
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:02a658d27e0791884d29e7a73a32d944
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    2-氨基-2-恶唑啉,VII:结构参数对 5-(1-Aryl-4-piperazino) 甲基-2-氨基-2-恶唑啉抗抑郁活性的影响
    摘要:
    已制备并筛选了一系列 5- (1- 芳基 - 4- 哌嗪基) 甲基- 2- 氨基- 2- 恶唑啉的抗抑郁活性。它们的亲脂行为已经与芳环上取代物的性质和位置有关。已经使用实验方法(X 射线衍射、核磁共振)和理论计算(半经验量子力学)研究了空间效应对药理活性的影响。苯环上的邻位取代或哌嗪环上的 C-α 被甲基取代会导致相同的效果,即两个环之间的角度增加至 64°(X 射线和计算)和抗抑郁活性的丧失。使用 NMR,仅观察到邻位取代的影响。
    DOI:
    10.1002/ardp.19943270311
点击查看最新优质反应信息

文献信息

  • [EN] N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES<br/>[FR] DERIVES DE N-PHENYL-PIPERAZINE ET METHODES DE PROPHYLAXIE OU DE TRAITEMENT DE MALADIES ASSOCIEES AU RECEPTEUR 5HT2C
    申请人:ARENA PHARM INC
    公开号:WO2005016902A1
    公开(公告)日:2005-02-24
    The present invention relates to certain substituted N-phenyl-piperazine derivatives of Formula: (I) that are modulators of the 5HT2c receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2c receptor associated diseases or disorders, such as, obesity, Alzheimer Disease, erectile dysfunction and related disorders.
    本发明涉及某些Formula: (I)的取代N-苯基哌嗪衍生物,它们是5HT2c受体的调节剂。因此,本发明的化合物对于预防或治疗与5HT2c受体相关的疾病或紊乱,如肥胖症、阿尔茨海默病、勃起功能障碍及相关疾病,是有用的。
  • Benzo[f]naphthyridine derivatives, their preparation and compositions containing them
    申请人:——
    公开号:US20020137741A1
    公开(公告)日:2002-09-26
    Benzo[f]naphthyridine derivatives of formula (I): 1 benzo[f]naphthyridine derivatives and benzo[f]naphthyridine esters of formula (IVa): 2 aminoquinoline derivatives of formula (X): 3 processes for preparing such compounds; and compositions comprising them.
    苯并[f]萘啉衍生物的化学式(I):1苯并[f]萘啉衍生物和苯并[f]萘啉酯的化学式(IVa);2氨基喹啉衍生物的化学式(X);3制备这些化合物的方法;以及包含它们的组合物。
  • N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
    申请人:Smith Brian
    公开号:US20070179155A1
    公开(公告)日:2007-08-02
    The present invention relates to certain substituted N-phenyl-piperazine derivatives of Formula: (I) that are modulators of the 5HT 2c receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT 2c receptor associated diseases or disorders, such as, obesity, Alzheimer Disease, erectile dysfunction and related disorders.
    本发明涉及某些替代N-苯基哌嗪衍生物,其化学式为:(I),它们是5HT2c受体的调节剂。因此,本发明的化合物对于预防或治疗与5HT2c受体相关的疾病或疾病,如肥胖症、阿尔茨海默病、勃起功能障碍和相关疾病是有用的。
  • SUBSTITUTED INDOLES
    申请人:SCHADT Oliver
    公开号:US20090291963A1
    公开(公告)日:2009-11-26
    Substituted indoles of the formula (I) and physiologically acceptable derivatives and salts thereof, in which R 1 , D, E, R 12 , p, X 1 , E, G, X 2 and Z are as defined in claim 1 , exhibit particular actions on the central nervous system, especially 5HT reuptake-inhibiting and 5 HTx-agonistic and/or -antagonistic actions and in particular serotonin-agonistic and -antagonistic properties and can be employed as antipsychotics, neuroleptics, antidepressants, anxiolytics and/or antihypertonics. They can furthermore be employed as excitatory amino acid antagonists for combating neurodegenerative diseases, including cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction or psychoses
    公式(I)的取代吲哚及其生理上可接受的衍生物和盐,其中R1,D,E,R12,p,X1,E,G,X2和Z的定义如权利要求1所述,表现出对中枢神经系统的特定作用,特别是5HT再摄取抑制和5HTx-激动和/或-拮抗作用,并且具有特别的血清素激动和拮抗特性,可以用作抗精神病药,神经类药物,抗抑郁药,抗焦虑药和/或降压药。此外,它们还可以用作兴奋性氨基酸拮抗剂,以对抗神经退行性疾病,包括脑血管疾病,癫痫,精神分裂症,阿尔茨海默病,帕金森病,亨廷顿病,脑缺血,梗塞或精神病。
  • TETRAHYDROBENZINDOLE COMPOUNDS
    申请人:MEIJI SEIKA KAISHA LTD.
    公开号:EP0937715A1
    公开(公告)日:1999-08-25
    Since the compound of the present invention represented by the following formula (I) can strongly inhibit bonding of [3H]-serotonin and [3H]-5-CT to human serotonin 5-HT7 receptor subtype expressed in cultured cell line, the compound of formula (I) and pharmaceutically acceptable salts thereof can provide pharmaceutical conpositions for use in the treatment or prevention of mental diseases. [In the above formula, A is N, CH, C having a double bond or CR5; each of B and Z is independently N, CH or CR1, with the proviso that A is N when B and/or Z is N; R1 is a hydrogen atom, a halogen atom, a lower alkyl group, a cyano group, a trihalomethyl group, a hydroxy group, an alkoxy group, an alkylthio group, an alkylsulfinyl group, an alkylsulfonyl group, an alkoxycarbonyl group, a sulfamoyl group, an amino group, a substituted amino group, a carbamoyl group, an alkylcarbamoyl group, an acyl group or a carboxy group; R2 is a hydrogen atom or a lower alkyl group; R3 is a hydrogen atom, a lower alkyl group or an aralkyl group; R4 is a hydrogen atom, a halogen atom, a lower alkyl group, a hydroxy group, an alkoxy group, an acyl group, an alkoxycarbonyl group, a nitro group, an amino group, a substituted amino gropup, a carbamoyl group, an alkylcarbamoyl group or an acyloxy group; R5 is a lower alkyl group, a cyano group, a carbamoyl group, a carboxy group, an acyl group, an acyloxy group, an alkoxy group, an alkoxycarbonyl group, a trihalomethyl group or a hydroxy group; and n is an integer of 2 to 6.]
    由于下式(I)表示的本发明化合物能强烈抑制[3H]-serotonin和[3H]-5-CT与培养细胞系中表达的人5-羟色胺5-HT7受体亚型的结合,因此式(I)化合物及其药学上可接受的盐可提供用于治疗或预防精神疾病的药物组合。 [在上式中,A 是 N、CH、具有双键的 C 或 CR5;B 和 Z 各自独立地是 N、CH 或 CR1,但当 B 和/或 Z 是 N 时,A 是 N;R1 是氢原子、卤素原子、低级烷基、氰基、三卤甲基、羟基、烷氧基、烷硫基、烷基亚磺酰基、烷基磺酰基、烷氧基羰基、氨基磺酰基、氨基、取代氨基、氨基甲酰基、烷基氨基甲酰基、酰基或羧基; R2 是氢原子或低级烷基;R3 是氢原子、低级烷基或芳烷基; R4 是氢原子、卤素原子、低级烷基、羟基、烷氧基、酰基、烷氧羰基、硝基、氨基、取代氨基丙基、氨基甲酰基、烷基氨基甲酰基或酰氧基;R5 是低级烷基、氰基、氨基甲酰基、羧基、酰基、酰氧基、烷氧基、烷氧羰基、三卤甲基或羟基;以及 n 是 2 至 6 的整数。]
查看更多